NEW YORK (GenomeWeb) – The Centers for Medicare & Medicaid Services have officially reopened its national coverage determination for next-generation sequencing for advanced cancer patients in order seek public comments on germline testing.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.
This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.